What is Protalix Biotherapeutics Inc?
, a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 257.17M, and a P/E ratio of 12.7x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.